Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Cavaliere D, Pacilio CA, Ercolani G, Pieri F, Gurrieri L, Riva N, Jones R, De Vita A. Gabellone S, et al. Among authors: gurrieri l. Heliyon. 2024 Nov 22;10(23):e40596. doi: 10.1016/j.heliyon.2024.e40596. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39687122 Free PMC article. Review.
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).
Ridolfi L, Gurrieri L, Riva N, Bulgarelli J, De Rosa F, Guidoboni M, Fausti V, Ranallo N, Calpona S, Tazzari M, Petrini M, Granato AM, Pancisi E, Foca F, Dall'Agata M, Bondi I, Amadori E, Cortesi P, Zani C, Ancarani V, Gamboni A, Polselli A, Pasini G, Bartolini D, Maimone G, Arpa D, Tosatto L. Ridolfi L, et al. Among authors: gurrieri l. Front Immunol. 2024 Aug 13;15:1404861. doi: 10.3389/fimmu.2024.1404861. eCollection 2024. Front Immunol. 2024. PMID: 39192978 Free PMC article. Clinical Trial.
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D, Ranallo N, Azzali I, Di Iorio V, Sarnelli A, Manuela M, Amadori E, Fabbri L, Bartolini D, Tosatto L, Di Meco F, Gurrieri L, Riva N, Calabro L, Matteucci F, Paganelli G, Sansovini M. Severi S, et al. Among authors: gurrieri l. J Nucl Med. 2024 Sep 3;65(9):1409-1415. doi: 10.2967/jnumed.123.266956. J Nucl Med. 2024. PMID: 39142827 Free PMC article.
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment.
Vanni S, Miserocchi G, Gallo G, Fausti V, Gabellone S, Liverani C, Spadazzi C, Cocchi C, Calabrese C, De Luca G, Bassi M, Gessaroli M, Tomasetti N, Campobassi A, Pieri F, Ercolani G, Cavaliere D, Gurrieri L, Riva N, Recine F, Ibrahim T, Mercatali L, Jones R, De Vita A. Vanni S, et al. Among authors: gurrieri l. Exp Hematol Oncol. 2024 Aug 5;13(1):74. doi: 10.1186/s40164-024-00540-4. Exp Hematol Oncol. 2024. PMID: 39103896 Free PMC article.
Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
Miele E, Anghileri E, Calatozzolo C, Lazzarini E, Patrizi S, Ciolfi A, Pedace L, Patanè M, Abballe L, Paterra R, Maddaloni L, Barresi S, Mastronuzzi A, Petruzzi A, Tramacere I, Farinotti M, Gurrieri L, Pirola E, Scarpelli M, Lombardi G, Villani V, Simonelli M, Merli R, Salmaggi A, Tartaglia M, Silvani A, DiMeco F, Calistri D, Lamperti E, Locatelli F, Indraccolo S, Pollo B. Miele E, et al. Among authors: gurrieri l. Cancer Lett. 2024 Apr 28;588:216711. doi: 10.1016/j.canlet.2024.216711. Epub 2024 Feb 27. Cancer Lett. 2024. PMID: 38423245
52 results